NDRA: ENDRA Life Sciences Inc. Company Aggregate Debts

The price visualization for ENDRA Life Sciences (NDRA) on the GURU.Markets platform shows debt at 0.00, while the company relies on a stable staff of specialized engineers and software developers. The business is implementing non-contact ultrasonic methods for analyzing fat deposits in organs, replacing painful biopsies. Expanding the clinic network across Europe and the US minimizes bureaucratic certification hurdles and accelerates global sales.

NDRA: ENDRA Life Sciences Company Debts 07/04/2022 - 10/29/2026

ENDRA Life Sciences Inc. (NDRA) - metric breakdowns and financial figures

- share price and consensus valuation forecast:

Price Performance Chart ENDRA Corp|NDRA - Analyst Consensus Forecast

- market capitalization information:

Market Capitalization ENDRA|NDRA - Total Company Value

- balance sheet equity data:

Accounting Value of a Share ENDRA Life Sciences|NDRA - Company Book Value|Market Cap to Net Assets Ratio endrainc.com|NDRA - Company Total Assets

- issuer credit burden and liquidity indicators:

Fundamental company analysis:ENDRA Corp NDRA

Signature product of ENDRA Life Sciences Inc

The resilience of ENDRA Life Sciences (NDRA) is based on the capitalization of intellectual property in the field of ultrasound diagnostics and strategic alliances. An analysis of total financial liabilities allows for an assessment of default risk through the dynamics of the debt load relative to revenue, where increasing debt signals a potential cash flow gap, directly impacting the calculation of the issuer's fair share value.

Competing companies